Our 4 regional congresses on access to innovation and biosimilars were a great success!
Thank you to all who attended the regional meetings!
The CARE™ Faculty held 4 regional congresses as an extension of the National meeting held on April 6th, 2018 in Toronto, ON. These regional meetings served as a platform for health care providers and key stakeholders from across Canada to meet, discuss, and share opinions with regards to how biosimilars will impact Canadian healthcare. Regional perspectives were provided from several different stakeholders, including: specialists, advocacy groups, allied health care representatives, legal, payers, and Health Canada.
Stay tuned for Conference Highlights, coming soon!
Thursday, November 8, 2018
Sheraton Vancouver Wall Centre
1088 Burrard Street, Vancouver, BC
Thursday, November 1, 2018
The Westin Calgary
320 4th Avenue, SW, Calgary, AB
About the Events:
The CARE™ Faculty held regional congresses on Access to Innovation and Biosimilars in Ottawa, Halifax, Calgary and Vancouver. The aim of these meetings was to provide a platform for representatives involved in Canadian healthcare to interactively share, discuss, and debate their perspectives on access to innovative therapies and biosimilars in the Canadian landscape.
Recognizing both the potential impact on the Canadian healthcare system and the importance of involving stakeholders, the following groups shared their perspectives, concerns, wants and needs: Health Canada, public and private funding agencies, specialists, allied healthcare providers, advocacy groups and legal experts.
Time was allocated for interactive discussion. Information gathered will be used to inform future educational initiatives developed by the CARE™ Faculty.
Biosimilars are a relevant topic to the Canadian landscape, given the recent introduction of several biosimilars to market as well as others in development soon to be available to the Canadian consumer. The CARE™ Faculty has been looking at the impact of biosimilars since 2015, and its significance across both chronic & acute diseases. The CARE™ faculty is interested in better understanding the impact of access to innovation and biosimilars and sharing this understanding with contemporaries.
CARE™ (Community, Academic, Research, Education) believes in: optimization of current therapy, innovative treatments, and competition to help deliver savings and accessibility, considered in ways that deliver better healthcare solutions to Canadians.